Skip to main content
Clinical Trials/ISRCTN90062954
ISRCTN90062954
Active, not recruiting
未知

Multi-parameter analysis of platelet function: the impact of cardiometabolic disease

niversity of Reading0 sites400 target enrollmentMarch 31, 2021

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
niversity of Reading
Enrollment
400
Status
Active, not recruiting
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 31, 2021
End Date
August 3, 2025
Last Updated
5 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
niversity of Reading

Eligibility Criteria

Inclusion Criteria

  • Under investigation for stable ischaemic heart disease and scheduled for coronary angiography as part of clinical care

Exclusion Criteria

  • 1\. Acute Coronary Syndrome in the past 12 months
  • 2\. P2Y12 inhibitors (including clopidogrel, tricagreolor and prasugrel)
  • 3\. Treatment dose anti\-coagulation, including warfarin or novel anti\-coagulant drugs (NOACS)
  • 4\. Other metabolic dysfunction
  • 5\. Evidence of alcohol or drug misuse
  • 6\. Unable to give informed consent
  • 7\. Aged \<18 years
  • 8\. Pregnancy
  • 9\. Active or recent malignancy (\<2 years)
  • 10\. Any underlying haematological pathologies

Outcomes

Primary Outcomes

Not specified

Similar Trials